Obsessive Compulsive Disorder (OCD) Study
Troriluzole as an Adjunctive Treatment for Obsessive Compulsive Disorder (OCD)
The Michigan Clinical Research Institute is currently enrolling those who have been diagnosed with OCD, and have received inadequate response from their current treatment.
An individual may qualify for the study if they:
- Are 18-65 years of age
- Have been diagnosed with Obsessive Compulsive Disorder (OCD)
- Have had no response or inadequate response from the current medications they are taking to treat this condition
- Meet additional study criteria
Reimbursement for reasonable, out-of-pocket expenses such as travel and accommodations may be available to qualified individuals.
Contact us or fill out the form below so we can reach out to you and move forward with pre-screening questions to assess your overall eligibility.